The Emory Antibiotic Resistance Center fights "superbugs" by tracking them, figuring out how they work, preventing their spread, and finding ways to kill them.
Thrilled to be part of this effort!
The Weiss Lab is HIRING at all levels. Come join us to study heteroresistance and how tiny subpopulations of resistant cells can have huge impacts on treatment outcomes.
Please RT and DM or email if interested.
https://t.co/XzetvXTstC.
We agree @Dr_Lori_Burrows. Unfortunately we observed much more heteroresistance than resistance, and in strains with a diversity of metallo-beta-lactamases including NDM1 which is spread globally
https://t.co/bXoG9j2V7A
Unfortunately we detected a LOT of heteroresistance to cefepime-taniborbactam among metallo-beta-lactamase encoding CRE (29/34 strains). Worse - most of it undetected by standard testing. Congrats @abbott_carter on your hard work and these important data. Thanks @TheLancetInfDis
Exciting news! I'm happy to announce I've been appointed as the Thomas J. Lawley, MD Professor in Dermatology! I'm so proud to carry on Dr. Lawley's great legacy of service & leadership in medicine. Thank you @EmoryMedicine & to my amazing colleagues at @EmoryDerm !
New! Gram- cells need lipoproteins to build their surface. LolA & LolB deliver these in E.coli. But many species only have LolA - where's LolB? For Caulobacter, LolB is... LolA! It's a bifunctional protein! We can even tweak E.coli LolA to do double duty! https://t.co/NKyaLp5t05
Science communications matter more than ever, so you know we're proud of @QuaveEthnobot of @emorycshh for being honored today in Washington DC by @TheNASEM for her commitment to public science outreach. Details ➡️ https://t.co/x5L7AkYbvb
6th Texas Medical Center Conference on Antimicrobial Resistance & Stewardship Houston, TX, January 18-20th, 2023. Abstract deadline December 2nd, 2022 . In cooperation with @ARLGnetwork ; T32 programs in Houston, Emory and UPitt. @asm_tmc@ASMicrobiology
https://t.co/FyqwherFMg
THE MOLD THAT CHANGED THE WORLD 🌎 🧫
Thrilled to be here for the opening night of the incredible play on the discovery of penicillin now brought to #ATL!!!
The art on display, the opening panel of experts, and next…. the musical!
@cdcfound & @EmoryUniversity
Our chorus member @briankhammer was saved by antibiotics when he was a child after developing a serious staphylococcal infection.... Read his story and why he thinks this show is so important. https://t.co/o3iARtJreT #AntimicrobialResistance#musicaltheatre#sciencemeetsart
Consider Joining This Free Workshop (In Person or Online): Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance https://t.co/JN7o8A5tsk via @theNASEM
Fact: Sepsis is a leading cause of death in hospitals, killing nearly 270,000 adults in the U.S. each year. Without new types of #antibiotics that can overcome resistance, that number will only increase. #SepsisAwarenessMonth https://t.co/Srug5hrAHm
On this month's episode of #SuperbugsUnplugged, Dr. Everly Macario shares the harrowing story of losing her young son to an #antibiotic resistant infection. Tune in to hear why reducing antibiotic use is key to saving lives.
I’m so proud of the incredible team effort that went into this manuscript. Congrats to all involved @jake_choby, @tugba6ozturk, @abbott_carter, @SarahSatola.
We hope antibiotic developers will consider #heteroresistance which may save time, $$, and greatly improve efficiency.
“1.27M people are dying of #AMR bacteria per year, as small research teams are breaking up. The intellectual capacity around the world is being diminished. We must replenish the next generation who can develop antibiotics.” - @koutterson@TheHillEvents
https://t.co/sU4tczucM6
"We rely on antibiotics. It's difficult to imagine a world without them. The economic impact and loss of human lives would be enormous. This is an opportunity for us to lead the world." -@SenatorBennet@TheHillEvents#TheHillHealth https://t.co/sU4tczucM6